leading to issues such as blepharitis (eyelid inflammation). While not everyone experiences symptoms, an overgrowth of ...

According to the AAO, Blepharitis is inflammation of the ... lash mites are actually caused by poor hygiene." Eyelash mites, ...

Currently, patients with Demodex blepharitis try to manage the condition ... which anecdotally can help discourage mites. Medicated ointments containing drugs like ivermectin, metronidazole ...

Several factors contribute to blepharitis, mainly bacterial infections, Allergies, Acne (rosacea) Meibomian gland dysfunction (MGD) and Demodex - lice or mite infestation. Other risk factors ...

Its product candidate, TP-03, is a novel therapeutic in Phase 2b/3 that is being developed for the treatment of blepharitis caused by the infestation of Demodex mites, which is referred to as ...

Tarsus Pharmaceuticals, Inc.’s TARS share price has dipped by 6.95%, which has investors questioning if this is right time to buy.

Tarsus Pharmaceuticals Inc. (Nasdaq: TARS), ranked No. 1 in the midsize category, has become a standout in OC’s biotech ...

is infested with mites called ' Demex mites.' Dr. Alejandra Perotti, who studies Demodex mites at the University of Reading in the UK, explains the biology of Demodex mites, which live in the ...

Its product candidate, TP-03, is a novel therapeutic in Phase 2b/3 that is being developed for the treatment of blepharitis caused by the infestation of Demodex mites, which is referred to as ...

The company’s lead product candidate is XDEMVY, a novel therapeutic for the treatment of blepharitis caused by the infestation of Demodex mites, as well as to treat meibomian gland disease.